No Data
No Data
H.C. Wainwright Maintains Karyopharm Therapeutics(KPTI.US) With Buy Rating, Cuts Target Price to $56
Express News | Trading Halt: Halt Status Updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times
Express News | Karyopharm Therapeutics Inc : H.c. Wainwright Adjusts Target Price to $56 From $7 to Reflect 1-for-15 Reverse Stock Split
Express News | Trading Halt: Halted at 7:50:00 P.m. ET - Trading Halt: Halt News Pending
Karyopharm Therapeutics To Carry Out 1-for-15 Reverse Stock Split On February 26th, 2025
Express News | Karyopharm Announces 1-for-15 Reverse Stock Split
xcinvest : i thought you needed to rest…? pls rest…
合理化烟雾 : thank you very much, bro
iluvpoptarts xcinvest : ye he tricked us . probably a bot. not even real person. heh
iluvpoptarts : thx doc
Riyan5426 : thank you. have a good rest![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
View more comments...